{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T19:43:38Z","timestamp":1768938218561,"version":"3.49.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There are challenges associated with the timely diagnosis of people with mild cognitive impairment (MCI) and Alzheimer's disease (AD), especially with the future introduction of amyloid-targeting therapies. This study evaluates the current diagnostic journey for MCI and dementia due to AD in Spain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study used data from the Adelphi Real World Dementia Disease Specific Programme (DSP\n                      <jats:sup>TM<\/jats:sup>\n                      ), a cross-sectional survey with retrospective data collection. The survey involved primary care physicians (PCPs) and hospital specialists with experience in managing and treating AD, along with their consulting patients, between January and July 2023 in Spain. Analyses were descriptive.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Physicians (\n                      <jats:italic>N<\/jats:italic>\n                      = 94; 44.7% PCPs, 38.3% neurologists) reported data for 723 patients. Most patients (78.9%) first consulted a PCP. The median (inter-quartile range) time since symptom onset to first consultation was 21.6 (6.1\u201348.2) weeks and, in those patients who were not diagnosed immediately, the time from first consultation to diagnosis was 13.0 (6.0\u201321.9) weeks if diagnosed by a PCP, or 28.9 (17.1\u201352.1) weeks if diagnosed by a specialist. The diagnosing physician was a specialist or a PCP for 83.2% and 16.8% of patients, respectively. In addition, the most used advanced diagnostic techniques were computed tomography scans and magnetic resonance imaging (57.2% and 43.3% of patients, respectively). CSF determination of AD biomarkers was conducted in 12.4% of patients and AD-specific blood biomarkers in 2.9%. Treatment was mostly initiated by neurologists.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The diagnostic process for people with MCI and AD could be accelerated by increased awareness of the disease, shorter referral times, and better access to specialized diagnostic services. This study shows limited use of AD-specific biomarker testing in Spain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1702805","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:28:12Z","timestamp":1768886892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The diagnostic pathway of Alzheimer's disease in real-world clinical practice in Spain: results from the Adelphi Dementia Disease Specific Programme\u2122"],"prefix":"10.3389","volume":"16","author":[{"given":"Pascual","family":"S\u00e1nchez-Juan","sequence":"first","affiliation":[{"name":"Reina Sof\u00eda Alzheimer Center, CIEN Foundation, Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Baz","sequence":"additional","affiliation":[{"name":"Centro de Salud Periurbana Norte","place":["Salamanca, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Arrieta","sequence":"additional","affiliation":[{"name":"Centro de Salud Segovia Rural","place":["Segovia, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Novick","sequence":"additional","affiliation":[{"name":"Eli Lilly & Company","place":["Arlington, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"D\u00edaz-Cerezo","sequence":"additional","affiliation":[{"name":"Eli Lilly & Company","place":["Alcobendas, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Cotton","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Walker","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Trueba Saiz","sequence":"additional","affiliation":[{"name":"Eli Lilly & Company","place":["Alcobendas, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Eli Lilly & Company","place":["Alcobendas, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","article-title":"The Alzheimer's disease clinical spectrum: diagnosis and management","volume":"103","author":"Atri","year":"2019","journal-title":"Med Clin North Am."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JAD-201059","article-title":"New frontiers in the prevention, diagnosis, and treatment of Alzheimer's disease","volume":"82","author":"Guzman-Martinez","year":"2021","journal-title":"JAD."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s11606-018-4377-y","article-title":"Underdiagnosis of dementia: an observational study of patterns in diagnosis and awareness in US older adults","volume":"33","author":"Amjad","year":"2018","journal-title":"J Gen Intern Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e6158","DOI":"10.1002\/gps.6158","article-title":"Systematic review on the evidence of misdiagnosis in dementia and its impact on accessing dementia care","volume":"39","author":"Giebel","year":"2024","journal-title":"Int J Geriatr Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/joim.13244","article-title":"Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis","volume":"290","author":"Liss","year":"2021","journal-title":"J Intern Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2023.11703","article-title":"Amyloid-targeting monoclonal antibodies for Alzheimer disease","volume":"330","author":"Rabinovici","year":"2023","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.21109","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/biomedicines8110457","article-title":"Depression as a risk factor for dementia and Alzheimer's disease","volume":"8","author":"Cant\u00f3n-Habas","year":"2020","journal-title":"Biomedicines."},{"key":"B12","unstructured":"\u201cImpacto sociosanitario en Espa\u00f1a de la enfermedad de Alzheimer y otras demencias,\u201d Impacto sociosanitario de las enfermedades neurol\u00f3gicas en Espa\u00f1a\n          \n          \n            \n              Zapata Arriaza\n              E\n            \n            \n              L\u00f3pez Fern\u00e1ndez\n              JC\n            \n          \n          \n          2024"},{"key":"B13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13195-023-01271-0","article-title":"Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact","volume":"15","author":"Olazar\u00e1n","year":"2023","journal-title":"Alzheimers Res Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e12130","DOI":"10.1002\/dad2.12130","article-title":"General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries\u2014A MOPEAD project survey","volume":"13","author":"Sannemann","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e12334","DOI":"10.1002\/dad2.12334","article-title":"Alzheimer's disease diagnosis and management: perspectives from around the world","volume":"14","author":"Kerwin","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1290002","DOI":"10.3389\/fpsyt.2023.1290002","article-title":"Medical help-seeking intentions among patients with early Alzheimer's disease","volume":"14","author":"Villarejo-Galende","year":"2023","journal-title":"Front Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s40120-022-00367-3","article-title":"Awareness of diagnosis in persons with early-stage Alzheimer's disease: an observational study in Spain","volume":"11","author":"Villarejo-Galende","year":"2022","journal-title":"Neurol Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4942562","DOI":"10.1155\/2019\/4942562","article-title":"Physician practice patterns associated with diagnostic evaluation of patients with suspected mild cognitive impairment and Alzheimer's disease","volume":"2019","author":"Judge","year":"2019","journal-title":"Int J Alzheimers Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/gps.5223","article-title":"Pathways to care for people with dementia: an international multicentre study","volume":"35","author":"Volpe","year":"2020","journal-title":"Int J Geriatr Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/ADR230007","article-title":"Current diagnostic pathways for Alzheimer's disease: a cross-sectional real-world study across six countries","volume":"7","author":"Roth","year":"2023","journal-title":"J Alzheimers Dis Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1177\/13872877251322978","article-title":"Diagnostic journey and current management of patients with mild cognitive impairment and Alzheimer's disease, and challenges associated with timely diagnosis: a multinational, real-world survey","volume":"104","author":"Vasileva-Metodiev","year":"2025","journal-title":"J Alzheimer's Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","article-title":"Real-world physician and patient behaviour across countries: disease-Specific Programmes - a means to understand","volume":"24","author":"Anderson","year":"2008","journal-title":"Curr Med Res Opin."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e010352","DOI":"10.1136\/bmjopen-2015-010352","article-title":"Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme","volume":"6","author":"Babineaux","year":"2016","journal-title":"BMJ Open."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","article-title":"Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes","volume":"39","author":"Anderson","year":"2023","journal-title":"Curr Med Res Opin."},{"key":"B25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/DMSO.S120101","article-title":"Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015","volume":"9","author":"Higgins","year":"2016","journal-title":"Diabetes Metab Syndr Obes."},{"key":"B26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3233\/JAD-200774","article-title":"Incidence of dementia and associated factors in the EPIC-Spain dementia cohort","volume":"78","author":"Andreu-Rein\u00f3n","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3233\/JAD-190760","article-title":"Multi-national, cross-sectional survey of healthcare resource utilization in patients with all stages of cognitive impairment, analyzed by disease severity, country, and geographical region","volume":"75","author":"Khandker","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.3390\/ijerph17103398","article-title":"Prevalence of comorbidities in individuals diagnosed and undiagnosed with Alzheimer's disease in Le\u00f3n, Spain and a proposal for contingency procedures to follow in the case of emergencies involving people with Alzheimer's disease","volume":"17","author":"Tortajada-Soler","year":"2020","journal-title":"Int J Environ Res Public Health."},{"key":"B29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3233\/JAD-220696","article-title":"Quality of life and the experience of living with early-stage Alzheimer's disease","volume":"90","author":"Villarejo-Galende","year":"2022","journal-title":"J Alzheimers Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1934","DOI":"10.1002\/mpr.1934","article-title":"Clinically significant anxiety as a risk factor for Alzheimer's disease: results from a 10-year follow-up community study","volume":"32","author":"Gracia-Garc\u00eda","year":"2023","journal-title":"Int J Methods Psych Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1007\/s10072-022-06068-x","article-title":"Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline","volume":"43","author":"Botto","year":"2022","journal-title":"Neurol Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7039","DOI":"10.3390\/jcm13237039","article-title":"The association between major depression and Alzheimer's disease risk: evidence from a 12-year longitudinal study","volume":"13","author":"Sevil-P\u00e9rez","year":"2024","journal-title":"JCM."},{"key":"B33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.nrleng.2016.10.002","article-title":"Prevalence of cognitive impairment in Spain: the G\u00f3mez de Caso study in health sentinel networks","volume":"33","author":"Vega Alonso","year":"2018","journal-title":"Neurologia."},{"key":"B34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/00325481.2023.22170s25","article-title":"Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia","volume":"135","author":"Brunton","year":"2023","journal-title":"Postgrad Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e091599","DOI":"10.1136\/bmjopen-2024-091599","article-title":"Designing a multicomponent intervention to support caregivers of persons with dementia in primary care in Spain: a qualitative study of family and professional carers","volume":"14","author":"Curto Romeu","year":"2024","journal-title":"BMJ Open."},{"key":"B36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1590\/S1980-57642011DN05040011","article-title":"Factors influencing possible delay in the diagnosis of Alzheimer's disease: findings from a tertiary Public University Hospital","volume":"5","author":"de Miranda","year":"2011","journal-title":"Dement Neuropsychol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1186\/s12913-019-4603-2","article-title":"Dementia assessment and management in primary care settings: a survey of current provider practices in the United States","volume":"19","author":"Bernstein","year":"2019","journal-title":"BMC Health Serv Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"100093","DOI":"10.1016\/j.nbas.2023.100093","article-title":"Rethinking the detection and diagnosis of Alzheimer's disease: outcomes of a European Brain Council project","volume":"4","author":"Dumas","year":"2023","journal-title":"Aging Brain."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e095446","DOI":"10.1002\/alz.095446","article-title":"Diagnostic journey and barriers to diagnosis for patients with mild cognitive impairment or dementia due to Alzheimer's disease in Canada: results from a real-world survey","volume":"20","author":"Glass","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B40","doi-asserted-by":"publisher","first-page":"100035","DOI":"10.1016\/j.tjpad.2024.100035","article-title":"Roberts JS. Determinants of dementia diagnosis in US primary care in the past decade: a scoping review","volume":"12","author":"Cox","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/JAD-200350","article-title":"Caregivers' sense of coherence: implications on direct and indirect costs of dementia care","volume":"78","author":"Turr\u00f3-Garriga","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.nrleng.2018.03.006","article-title":"Blood biomarkers in Alzheimer's disease","volume":"36","author":"Altuna-Azkargorta","year":"2021","journal-title":"Neurologia."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.nrl.2024.08.002","article-title":"Biomarcadores en sangre para la enfermedad de Alzheimer: posicionamiento y recomendaciones de uso del Grupo de Estudio de Conducta y Demencias de la Sociedad Espa\u00f1ola de Neurolog\u00eda","volume":"40","author":"Su\u00e1rez-Calvet","year":"2025","journal-title":"Neurolog"},{"key":"B45","doi-asserted-by":"publisher","first-page":"100056","DOI":"10.1016\/j.tjpad.2024.100056","article-title":"Cutting through the noise: a narrative review of Alzheimer's disease plasma biomarkers for routine clinical use","volume":"12","author":"Sch\u00f6ll","year":"2025","journal-title":"J Prev Alzheimer's Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1474-4422(23)00447-7","article-title":"European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders","volume":"23","author":"Frisoni","year":"2024","journal-title":"Lancet Neurol."},{"key":"B47","unstructured":"Gu\u00eda oficial de pr\u00e1ctica cl\u00ednica en demencia\n          \n          \n            \n              Manzano\n              MS\n            \n            \n              Fortea\n              J\n            \n            \n              Villarejo\n              A\n            \n            \n              S\u00e1nchez del Valle\n              R\n            \n          \n          Soc. Esp. Neurol.\n          \n          2018"},{"key":"B48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40266-017-0446-x","article-title":"Trends in the prescription and long-term utilization of antidementia drugs among patients with Alzheimer's disease in Spain: A cohort study using the registry of dementias of Girona","volume":"34","author":"Calv\u00f3-Perxas","year":"2017","journal-title":"Drugs Aging."},{"key":"B49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/JAD-220471","article-title":"Real-world use of symptomatic treatments in early Alzheimer's disease","volume":"91","author":"Garcia","year":"2023","journal-title":"J Alzheimers Dis."},{"key":"B50","unstructured":"Code of Conduct\n          \n          2022"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1702805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:28:14Z","timestamp":1768886894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1702805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":50,"alternative-id":["10.3389\/fneur.2025.1702805"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1702805","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"article-number":"1702805"}}